nach oben

The journal of nutrition, health & aging

Erschienen in:

16.10.2015

Effects of Artemisia princeps supplementation on bone metabolism in ovariectomized rats

verfasst von: H.-J. Cho, J.-W. Kim, S.-Y. Ju, Yoo-Kyoung Park

Erschienen in: The journal of nutrition, health & aging | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the effects of Artemisia princeps (AP) extract on bone metabolism and its potential role in the prevention of osteoporosis in ovariectomized rats. Twenty-six female Sprague-Dawley rats were divided into five groups and treated as follows: sham-operated control group (SHAM); ovariectomized control group (OVX), ovariectomized group treated by gavage with 10 mg/kg/day alendronate (ALEN); ovariectomized group treated by gavage with 100 mg/kg/day Artemisia princeps (AP100); ovariectomized group treated by gavage with 300 mg/kg/day Artemisia princeps (AP300). Treatment of ovariectomized rats with AP extracts for 15 weeks prevented the reduction in bone thickness and trabecular bone mineral density caused by urinary Ca and Cr excretion, and also prevented the increase in bone turnover by maintaining the serum Ca/P ratio. As a result, the microarchitecture of the trabecular bone and cortical bone after ovariectomy was markedly improved by administration of AP extracts. In conclusion, AP prevented bone loss and osteoclast activity associated with high bone turnover in ovariectomized rats by controlling the serum Ca/P ratio and through anti-inflammatory and anti-oxidant properties. Our data implicate AP as a promising therapeutic option for the improvement of postmenopausal osteoporosis.

Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab 2012;97(2):311–325.CrossRefPubMedPubMedCentral

Dixon, J. M. Hormone replacement therapy and the breast. BMJ 2001;323(7326):1381–1382.CrossRefPubMedPubMedCentral

Marcus, R. Post-menopausal osteoporosis. Best Pract Res Clin Obstet Gynaecol 2002;16(3):309–327.CrossRefPubMed

Coxam V. New advances in osteoporosis nutritional prevention. Med Sci(Paris) 2005;21(3):297–301.

Dempster, D. W., & Lindsay, R. Pathogenesis of osteoporosis. Lancet 1993;341(8848):797–801.CrossRefPubMed

Cooper, C., & Aihie, A. Osteoporosis. Baillieres Clin Rheumatol 1995;9(3):555–564.CrossRefPubMed

Riggs, B. L., Jowsey, J., Kelly, P. J., Jones, J. D., & Maher, F. T. Effect of sex hormones on bone in primary osteoporosis. J Clin Invest 1969;48(6):1065–1072.CrossRefPubMedPubMedCentral

Park SR, Oreffo RO, Triffitt JT. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 1999;24(6):549–54.CrossRefPubMed

Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143–147.CrossRefPubMed

10.

Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355(9222):2185–8.CrossRefPubMed

11.

Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000;355(9222):2218–9.CrossRefPubMed

12.

Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283(24):3205–10.CrossRefPubMed

13.

Lawrence M, Jones L, Lancaster T, Daly E, Banks E. Hormone replacement therapy: patterns of use studied through British general practice computerized records. Fam Pract 1999;16(4): 335–42.CrossRefPubMed

14.

Boulbaroud, S., Mesfioui, A., Arfaoui, A., Ouichou, A., & el-Hessni, A. Preventive effects of flaxseed and sesame oil on bone loss in ovariectomized rats. Pak J Biol Sci 2008;11(13):1696–1701.CrossRefPubMed

15.

Schmidt JW, Wollner D, Curcio J, Riedlinger J, Kim LS. Hormone replacement therapy in menopausal women: Past problems and future possibilities. Gynecol Endocrinol 2006;22(10):564–77.CrossRefPubMed

16.

Liu HC, Chen RM, Jian WC, Lin YL. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J Formos Med Assoc 2001;100 (6):383–8.PubMed

17.

Geissman TA. Sesquiterpenoid lactones of Artemisia species. I. Artemisia princeps pamp. J Org Chem 31(8):2523-6.

18.

Yamada H, Ohtani K, Kiyo1966;hara H, Cyong JC, Otsuka Y, Ueno Y, Omura S. Purification and chemical properties of anti-complementary polysaccharide from the leaves of Artemisia princeps. Planta Med 1985;(2):121–5.CrossRefPubMed

19.

Kim MJ, Kim DH, Na HK, Oh TY, Shin CY, Surh Ph D Professor YJ. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human gastric cancer (AGS) cells. J Environ Pathol Toxicol Oncol 2005;24(4):261–9.CrossRefPubMed

20.

Boudjelal A, Siracusa L, Henchiri C, Sarri M, Abderrahim B, Baali F, Ruberto G. Antidiabetic Effects of Aqueous Infusions of Artemisia herba-alba and Ajuga iva in Alloxan-Induced Diabetic Rats. Planta Med 2015;81(9):696–704.CrossRefPubMed

21.

Kim MJ, Han JM, Jin YY, Baek NI, Bang MH, Chung HG, Choi MS, Lee KT, Sok DE, Jeong TS. In vitro antioxidant and anti-inflammatory activities of Jaceosidin from Artemisia princeps Pampanini cv. Sajabal. Arch Pharm Res 2008;31(4):429–437.CrossRefPubMed

22.

Hwang KE, Choi YS, Choi SM, Kim HW, Choi JH, Lee MA, Kim CJ. (2013) Antioxidant action of ganghwayakssuk (Artemisia princeps Pamp.) in combination with ascorbic acid to increase the shelf life in raw and deep fried chicken nuggets. Meat Sci 2013;95(3):593–602.CrossRefPubMed

23.

Lotfy AA, Ghanem LY, Shennawy AM, Gomaa NA, El-Said HH. Assessment of the toxicity of Artemisia inculta extract on the bone marrow of mice infected with schistosomiasis. Arzneimittelforschung 2006;56(2):104–7.PubMed

24.

Ryu R, Jung UJ, Kim HJ, Lee W, Bae JS, Park YB, Choi MS. Anticoagulant and Antiplatelet Activities of Artemisia princeps Pampanini and Its Bioactive Components. Prev Nutr Food Sci 2013;18(3):181–7.CrossRefPubMedPubMedCentral

25.

Petterino C, Argentino-Storino A. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol 2006;57(3): 213–9.CrossRefPubMed

26.

Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 2003;72(4):519–27.CrossRefPubMed

27.

Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 2004;279(38): 40007–16.CrossRefPubMed

28.

Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005;149:240–60.CrossRefPubMed

29.

Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 2006;40(9):1483–93.CrossRefPubMed

30.

A. Petkau. Protection of bone marrow progenitor cells by superoxide dismutase. Mol Cell Biochem 1988;84(2):133–40.CrossRefPubMed

31.

Michael J. Smietana, Ellen M. Arruda, John A. Faulkner, Susan V. Brooks, and Lisa M. Larkin. Reactive Oxygen Species on Bone Mineral Density and Mechanics in Cu, Zn Superoxide Dismutase (Sod1) Knockout Mice. Biochem Biophys Res Commun 2010;403(1):149–153.CrossRefPubMedPubMedCentral

32.

Colla S, Zhan F, Xiong W, Wu X, Xu H, Stephens O, Yaccoby S, Epstein J, Barlogie B, Shaughnessy JD. The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells. Blood 2007;109(10):4470–7.CrossRefPubMedPubMedCentral

33.

Ostalowska A, Birkner E, Wiecha M, Kasperczyk S, Kasperczyk A, Kapolka D, Zon-Giebel A. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthritis Cartilage 2006;14(2):139–45.CrossRefPubMed

34.

Maneesh M, Dutta S, Chakrabarti A, Vasudevan DM. Alcohol abuse-duration dependent decrease in plasma testosterone and antioxidants in males. Indian J Physiol Pharmacol 2006;50(3):291–6.PubMed

35.

Kim J, Kim Y, Yi H, Jung H, Rim YA, Park N, Jung SM, Park SH, Ju JH. Eupatilin ameliorates collagen induced arthritis. J Korean Med Sci 2015;30(3):233–9.CrossRefPubMedPubMedCentral

36.

Lee JA, Sung HN, Jeon CH, Gill BC, Oh GS, Youn HJ, Park JH. AIP1, a carbohydrate fraction from Artemisia iwayomogi, modulates the functional differentiation of bone marrow-derived dendritic cells. Int Immunopharmacol 2008;8(4):534–41.CrossRefPubMed

37.

Kim MH. The Effects of Artemisia Princeps var. Orientalis Extracts on Serum Lipids and Connective Tissues Collagen in Ovariectomized Rats. Korean J Pharmacogn 2006;37(4):324–330.

38.

de Toro Salas A, Dueñas Díez J, de Jaime Revuelta E. Concentrations of calcium and bone remodeling biomarkers in umbilical cord blood and urine of newborn infants during delivery. An Esp Pediatr 2001;54(3):290–6.CrossRefPubMed

39.

Argenzio RA, Lowe JE, Hintz HF, Schryver HF. Calcium and phosphorus homeostasis in horses. J Nutr 1974;104(1):18–27.PubMed

40.

Yoshiko Y, Candeliere GA, Maeda N, Aubin JE. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 2007;27(12):4465–74.CrossRefPubMedPubMedCentral

41.

Locker FG. Hormonal regulation of calcium homeostasis. Nurs Clin North Am 31(4):797-803.

42.

B1996;ajammal SS, Zlowodzki M, Lelwica A, Tornetta P, Einhorn TA, Buckley R, Leighton R, Russell TA, Larsson S, Bhandari M. The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials. J Bone Joint Surg Am 2008;90 (6):1186–96.CrossRefPubMed

43.

Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992;75(1):176–82.PubMed

44.

Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 1989;86(7):2398–402.CrossRefPubMedPubMedCentral

45.

Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 1991;88(12):5134–8.CrossRefPubMedPubMedCentral

46.

Rizzoli R. Bisphosphonates for post-menopausal osteoporosis: are they all the same? QJM 2011;104(4):281–300.CrossRefPubMed

47.

Sauty A, Pecherstorfer M, Zimmer-Roth I, Fioroni P, Juillerat L, Markert M, Ludwig H, Leuenberger P, Burckhardt P, Thiebaud D. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 1996;18(2):133–9.CrossRefPubMed

48.

Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V. The acute-phase response after bisphosphonate administration. Calcif Tissue Int 1987;41(6):326–31.CrossRefPubMed

49.

Schweitzer DH, Oostendorp-van de Ruit M, Van der Pluijm G, Löwik CW, Papapoulos SE. Interleukin-6 and the acute phase response during treatment of patients with Paget’s disease with the nitrogen-containing bisphosphonate dimethylamino-hydroxy-propylidene bisphosphonate. J Bone Miner Res 10(6):956-62.

50.

Ryu KR, Choi JY, Chung S, Kim DH. Anti-scratching behavioral effect of the essential oil and phytol isolated from Artemisia princeps Pamp. in mice. Planta Med

Titel: Effects of Artemisia princeps supplementation on bone metabolism in ovariectomized rats
verfasst von: H.-J. Cho
J.-W. Kim
S.-Y. Ju
Yoo-Kyoung Park
Publikationsdatum: 16.10.2015
Verlag: Springer Paris
Erschienen in: The journal of nutrition, health & aging / Ausgabe 5/2016
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-015-0607-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Effects of Artemisia princeps supplementation on bone metabolism in ovariectomized rats

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

Frailty index and its relation to falls and overnight hospitalizations in elderly Chinese people: A population-based study

Prevalence and determinants of metabolic syndrome-identified by three criteria among men in rural China: A population-based cross-sectional study conducted during 2007-2008

Comparison of objective physical activity, muscle strength, and depression among community-dwelling older women living in sloped versus non-sloped environments

Letter to the Editor

Why is later age at retirement beneficial for cognition? Results from a French population-based study

Resveratrol requires red wine polyphenols for optimum antioxidant activity

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin